Torben Lund-Hansen

Torben Lund-Hansen has a strong background in the biotechnology industry, with experience in various leadership roles. Currently serving as the SVP and Chief Technical Officer at Y-mAbs Therapeutics, Inc., Torben previously founded and led Lund-Hansen Consulting ApS. With a PhD in Biochemistry from the University of Copenhagen, Torben has held positions at companies such as Genmab A/S, Maxygen, and Novo Nordisk A/S. A well-rounded professional with a history of success in the field.